Expression of feline leukaemia virus gp85 and gag proteins and assembly into virus-like particles using the baculovirus expression vector system
Darrell R. Thomsen,* Annette L. Meyer and Leonard E. Post Molecular Biology Research, The Upjohn Company, 301 Henrietta Street, Kalamazoo, Michigan 49007, U.S.A. In order to test components of feline leukaemia virus (FeLV) as subunit vaccines, we have constructed recombinant baculoviruses that express the FeLV envelope glycoprotein gp85 [Autographa californica nuclear polyhedrosis virus (AcNPV)-gp85] and the structural protein, gag (AcNPVgag). The gag protein is expressed and shed into the medium of infected cells as particles which have a buoyant density on sucrose gradients and appearance by electron microscopy similar to those of authentic FeLV virions. The gag precursor protein within the particles is not fully processed and appears to be a result of partial cleavage of the gag polypeptide. Insect cells that are coinfected with AcNPVgag and AcNPVgp85 shed particles that contain both the gag protein and the gp85 glycoprotein.
The oncornavirus feline leukaemia virus (FeLV) is a member of the Retroviridae family of viruses. In cats, FeLV can cause lymphoma, myeloproliferative diseases, leukaemia, immunodeficiency syndrome, aplastic anaemia and neurological disease (Rojko et al., 1988; Lutz, 1990) . Animals can be vaccinated against FeLV; however, the efficacy of these vaccines has been disputed (Henley et al., 1986; Sharpe, 1986; Osterhaus et al., 1987; Pollack & Scarlett, 1990) . The goal of this expression work was to produce sufficient quantities of env and gag for analysis as subunit vaccines. In this report we describe the construction of two recombinant baculoviruses that not only express the genes encoding gag and gp85 of FeLV but also assemble these subunits into immature virus-like particles which are shed into the medium of insect cells coinfected with both viruses.
The FeLV genome codes for three genes: a gag gene coding for the major structural components of the virus, an env gene which codes for the envelope glycoprotein, and apol gene encoding the polymerase protein. The gag gene is expressed as a 65K polyprotein which is processed into four subunits: 15K matrix protein, a 12K protein of unknown function, a 27K capsid protein and a 10K nucleocapsid protein. The pol gene encodes three proteins: protease, reverse transcriptase and integrase. Autoprocessing by the protease portion of the gene gives rise to all three proteins of the pol region. Additionally, the protease is responsible for the processing of the gag precursor (Baltimore, 1975; LaPrevotte et al., 1984) . The pol gene is expressed as a gag-pol fusion protein due to suppression of the gag termination codon at the gag-pol gene junction by a cellular tRNA Glu (Yoshinaka et al., 1985) . The env gene is expressed as an 85K glycoprotein, gp85, which is further processed to the disulphide-bound, membrane-associated 70K and 15K (plSE) complex found on the surface of the virion .
The baculovirus expression vector system (BEVS) has been used by many researchers to express mammalian viral proteins and glycoproteins (Luckow & Summers, 1988; Luckow, 1990) . Several groups have expressed the surface glycoprotein of two other retroviruses, human immunodeficiency virus (HIV) (Hu et al., 1987; Rusche et al., 1987; Wells & Compans, 1990 ) and avian leukaemia virus (Noteborn et al., 1990) , in insect cells. Others have expressed the retroviral gag gene and found that the expressed protein assembles into virus-like particles in infected insect cells (Madisen et al., 1987; Delchambre et al., 1989; Gheysen et al., 1989; Overton et al., 1989; Luo et al., 1990; Rasmussen et al., 1990; Morikawa et al., 1991) .
The parent baculovirus Autographa californica nuclear polyhedrosis virus (AcNPV) E2 strain was obtained from Max Summers (Texas A & M University College Station, Tx., U.S.A.). The Spodopterafrugiperda cell line, Sf9, was obtained from the ATCC (CRL 1711). The cells, parent viruses and recombinant viruses were propagated by methods described in detail by Summers & Smith (1987) .
FeLV subgroup A was purified from the supernatant of a persistently infected CRFK cell lilac, FeLV-A/FGA (Cole el al., 1990) provided by Jack Nunberg (Cetus Corporation). FeLV-A/FGA cells were grown in Dulbecco's modified Eagle's medium supplemented with 10 % foetal calf serum. The FeLV DNA constructs that were inserted into the transfer vector pVL941 are shown in Fig. 1 . For expression of the gag protein, a 2.2 kb XbaI-EcoRI fragment was removed by endonuclease digestion from the plasmid pFELVgag3 (obtained from J. Nunberg). This fragment contains the coding sequences for the FeLV gag gene, as well as the protease portion of the pol gene (nucleotides 517 to 2786) (Donahue et al., 1988) . The ends of this fragment were repaired using the Klenow enzyme and BamHI linkers were added. The fragment was then ligated into the BamHI site of plasmid pVL941 (Luckow & Summers, 1989) to produce pVLgag. For expression of the FeLV gp85 envelope protein in baculovirus, the gp85 gene was removed from plasmid pTC2 (provided by J. Nunberg) by digestion with PstI. A 2 kb fragment was isolated and the ends were repaired by treatment with T4 DNA polymerase followed by the addition of BamHI linkers. This BamHI fragment was ligated into the BamHI site of pVL941 to produce pVL85. Plasmids pVLgag and pVL85 were inserted into wild-type AcNPV using standard BEVS techniques (Summers & Smith, 1987) . Recombinant baculoviruses were selected and expression of the gag and gp85 proteins was confirmed by immunoprecipitation of [35S]methionine-labelled proteins from infected cells using monoclonal antibodies (MAbs) to gag or gp70 (data not shown).
When we began these experiments, the ability of our FeLV gag construct to direct the assembly of particles in infected cells was in question. Other workers had shown that gag genes from HIV (Gheysen et al., 1989; Overton et al., 1989; Luo et al., 1990) , simian immunodeficiency virus (Delchambre et al., 1989) , feline immunodeficiency virus (Morikawa et al., 1991) and bovine immunodeficiency virus (Rasmussen et al., 1990) expressed in BEVS could assemble and secrete immature virus-like particles. When the protease gene was co-expressed with the gag gene, in cis or trans, processing of gag occurred (Madisen et al., 1987; Gheysen et al., 1989; Overton et al., 1989; Morikawa et al., 1991 ) but particles were not formed (Gheysen et al., 1989; Overton et al., 1989; Morikawa et al., 1991) .
The recombinant virus designated AcNPVgag contains DNA encoding not only the gag product but also the protease portion of the pol gene. This construct could allow for the expression of the p65 gag precursor or a gag-protease fusion protein of 78K, if the gag termination signal were suppressed in insect cells as it is in FeLV-infected mammalian cells. This same gag-protease region has been inserted into the feline herpesvirus (FHV) genome (Cole et al., 1990 ). This recombinant virus was shown to produce both the gag gene product and a gag-protease fusion protein in infected cells. The protease was also shown to be active in processing gag (p65) into its four polypeptide components in recombinant FHV-infected cells.
To test for the assembly of virus-like particles the extracellular fluid of AcNPVgag-infected Sf9 cells was examined by sucrose gradient analysis, followed by electron microscopy (EM). Sf9 cells growing in 100 ml spinner flasks (1 x 106 cells/ml) were infected with the recombinant baculoviruses AcNPVgag, AcNPVgp85 or a control virus, AcNPVgp50, at an m.o.i, of 10 p.f.u./cell for singly infected cultures or 5 p.f.u./cell of each virus for doubly infected cultures. AcNPVgp50 is a recombinant virus that produces the gp50 glycoprotein gene from pseudorabies virus (Thomsen et al., 1990) . Infected cell cultures were harvested at 64 h post-infection. FeLV was harvested from the supernatants of persistently infected FeLV-A/FGA cells when the cells were confluent. Cells and cellular debris were removed by low-speed centrifugation. The supernatants were then centrifuged at 100000g for 1 h (Delchambre et al., 1989) . The pellets from these high-speed centrifugations were resuspended in PBS and layered onto 20 to 60~ sucrose gradients (in PBS) and centrifuged for 16 h at 100000g in an SW41 rotor. Gradients were fractionated from the top. Each fraction (0-5 ml) was analysed for sucrose concentration and protein content (BCA protein assay kit; Pierce Chemical). Western blots were used to detect particular proteins in each fraction. The presence of virus particles in some fractions was observed directly by EM. Typical gradient profiles are shown in Fig. 2(a) . Fractionation of the high-speed pellets from AcNPVgag-and AcNPVgp50-infected cell supernatants are shown. Both the AcNPVgag and the control AcNPVgp50 have a major protein peak in fractions 15 and 16. EM analysis of these fractions showed they contained baculovirus particles (data not shown). AcNPVgag-infected cell supernatants also show a protein shoulder in fraction 12. EM analysis of fraction 12 is shown in Fig. 2 A/FGA cell supernatant (Fig. 2b) . Peak fractions from the sucrose gradients (Fig. 2) were prepared for EM by mixing 50 ktl of the fraction with 100 ~1 of a 2~ phosphotungstic acid solution, pH 6.0, containing 0-05 bovine serum albumin. The mixture was transferred as a single drop to a carbon-formvar-coated grid (Ted Pella Inc.). The sample was allowed to adsorb for 30 s and excess fluid was removed by touching the edge of the grid with filter paper. Grids were observed at 60 kV on a JEOL 1200 transmission electron microscope. The insect cells produce particles which resemble immature FeLV particles in size (100 nm), shape and ring structure. Only immature particles were found in the baculovirusproduced material (Fig. 2c) whereas both mature and immature particles were found in the FeLV-A/FGA cell supernatant preparations (Fig. 2b) .
It appeared from these results that gag expression resulted in the formation of virus-like particles. We next examined, by Western blot, the nature of the gag product in the particles and looked for the incorporation of the envelope glycoprotein, gp85, into these particles on coinfection of insect cells with AcNPVgp85 and AcNPVgag. For this analysis, aliquots from each fraction of the gradients were separated on an 11 ~ N,N'-diallyltartardiamide-cross-linked polyacrylamide gel using the method of Laemmli (1970) . Following electrophoresis, proteins were electroblotted onto 0.22 txm nitrocellulose (Towbin et al., 1979) . Unoccupied sites on the nitrocellulose were blocked by sequential incubation in PBS containing 0-1~ Tween 20 and Tris-saline, pH 7.4, containing 0.1 ~ Brij-58. Blots were incubated with the primary antibody and colour development was carried out as previously described (Hink et al., 1991) . For detection of gag and gp70, MAbs were used (Lutz et al., 1981 (Lutz et al., , 1983 Grant et al., 1983) .
Western blots of gradient-fractionated FeLV particles produced by the FeLV-A/FGA cell line are shown in Fig.  3 (a) and (b) . These results provide information on how the natural gp85 and gag products appear when fractionated under conditions identical to those used for infected insect cell supernatants. Antibody against the envelope protein reacted with a single band corresponding to an Mr of 80K (Fig. 3a) in fractions 10 and 11. Antibody to p27 reacted with a 27K polypeptide in these same fractions (Fig. 3 b) . A large proportion of the gp70 remained near the top of the gradient, which we believe is due to it becoming detached from the virus particle during purification as previously reported (Zelikman et al., 1989) . A second band of approximately 35K is present in these fractions. This species has been found by others in FeLV-infected cells and is thought to arise by proteolytic cleavage of gp70 .
Immunoblot analysis of gradients from cells coinfected with AcNPVgag and AcNPVgp85 is shown in Fig. 3 (c) and (d) . The gp85 was found in fractions 10 and 11 just as gp70 was for FeLV in Fig. 3 (a) . A small amount was seen at the top of the gradient, but in a much lower proportion than that seen with the virus particles. When AcNPVgp85 singly infected cell supernatants were analysed similarly, no immunoreactive bands were found in the gradient (data not shown). We found no evidence that the gp85 glycoprotein was being processed to the gp70-pl5E complex found in virus particles (data not shown). This result was unexpected since the avian leukaemia virus envelope glycoprotein is cleaved in insect cells (Noteborn et al., 1990) . Cleavage of the HIV gpl60 glycoprotein has also been reported by some investigators (Cochran et al., 1987; Wells & Compans, 1990 ) whereas others found no processing (Hu et al., 1987; Rusche et al., 1987) . A MAb to pl 5E would answer this question; however, we do not have such an antibody at our disposal. Two forms of gp85 could be present in the particles, a 69K protein and a low abundance 60K species. Preliminary results indicate that the 60K polypeptide is an unglycosylated form of gp85 (data not shown). These same proteins are found in the fractions that contain baculovirus particles, fractions 13 to 16. Whether the latter event is due to specific incorporation or trapping is unknown. Clearly, gp85 was being incorporated into the immature particles found in the medium of infected cells. A question still remained as to the specificity of the gp85 interaction with gag. To test for specificity we coinfected cells with AcNPVgag and AcNPVgp70 (data not shown). The gp70 gene in the virus AcNPVgp70 was constructed to produce an envelope glycoprotein lacking the p 15E portion of the molecule. If the incorporation of surface glycoproteins were random, or if the 15K portion of the molecule were not acting as a recognition signal for gag, one would expect to find a gp70 immunoreactive polypeptide at the same density as that of gag particles. The results of this experiment showed no incorporation of gp70 at the density of gag particles. Gp70 reactivity occurred only at the top of the gradient. We also coinfected cells with AcNPVgag and AcNPVgp50. Again no gp50 was found at the density of gag particles (data not shown), indicating that the incorporation of gp85 into the particles is specific.
The gag profile of the gradient was more complicated (Fig. 3d) . Several polypeptides were immunoreactive with antibody to p27: 65K, 55K, 48K, 39K, 38K, 31K and 28K. The profile is identical to that found in the supernatants of AcNPVgag-infected cells (data not shown). In FeLV-infected cells the gag protein is produced as a 65K precursor which is processed by the protease portion of the pol gene product into the p 15, p 12, p27 and pl0 polypeptides. Since a MAb to p27 was used for the Western blot analysis only partially digested products that contain p27 should react on the blot. Partial digestion of the 65K precursor could yield 65K, 55K, 39K, 37K and 27K polypeptide bands. These values match the Mr of the polypeptides that we see in the particles formed in infected insect cells (Fig. 3d) . All but the 48K and 31K band can arise by the result of a partial digestion. These results hint, but do not prove, that the protease portion of our construct is active. This may mean that the termination signal at the gagprotease junction is being suppressed and that a gagprotease fusion protein is being translated and processed. Cellular proteases might also be responsible for these partial digestions. Others have shown that when the gag genes from other retroviruses are expressed in insect cells, gag is not processed unless an active retroviral protease gene is also expressed (Morikawa et al., 1991 ; Madisen et al., 1987; Overton et al., 1989; Gheysen et al., 1989) . This indicates that the FeLV gag precursor could be stable in infected insect cells. Deletion of the protease portion of our gag-pol construct followed by its expression in BEVS is required to determine which explanation is correct.
The results reported in this paper confirm the observations that expression of the gag gene from a retrovirus in insect cells leads to the production of viruslike particles. It extends this work by showing that, in a coinfection, the FeLV env protein gp85 can be specifically incorporated into these particles. In this study we cloned both the FeLV gag and env genes into the BEVS. Both genes showed altered processing when expressed in insect cells. However this aberrant processing did not appear to affect the assembly of virus-like particles.
The gp70 glycoprotein has been shown to elicit neutralizing antibodies (de Noronha et al., 1978; Nunberg et al., 1984) and immune-stimulating complexes formulated with gp70 also elicit neutralizing protective immune responses in cats (Osterhaus et al., 1985 Akerblom et al., 1989) . Recently, neutralizing epitopes on an HIV gag precursor have been described (Papsidero et al., 1989) . Perhaps as important as the neutralizing response is a cytolytic T cell response. Cytotoxic T lymphocytes are induced against both the gag and env gene products of Friend leukaemia virus (Holt et al., 1986) . HIV gag-env particles produced in mammalian cells have also been shown to produce a humoral and cellular immune response in rabbits (Haffar et al., 1991) . This suggests that particles containing both the gag protein and the env glycoprotein would be desirable in a vaccine designed to optimize the immune response. The assembled gag-env particles should provide an ideal structure for immunization much like the virus structures that form during a natural FeLV infection. The accompanying paper (Wardley et al., 1992) provides data on the immunological response in cats to these glycoproteins and proteins individually, in combination, and as virus-like particles.
